Innovative Pharmaceutical Biotech Limited (HKG:0399)
Hong Kong
· Delayed Price · Currency is HKD 0.2040
-0.0010 (-0.49%)
Jun 16, 2025, 10:19 AM HKT
HKG:0399 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.43 | 3.08 | 1.33 | 4.08 | 8.99 | 22.94 | Upgrade
|
| Cash & Short-Term Investments | 0.43 | 3.08 | 1.33 | 4.08 | 8.99 | 22.94 | Upgrade
|
| Cash Growth | -50.35% | 131.03% | -67.40% | -54.59% | -60.80% | 34.46% | Upgrade
|
| Accounts Receivable | 3.37 | 4.91 | 6.17 | 9.26 | 15.32 | 15.61 | Upgrade
|
| Other Receivables | - | 0.21 | 0.24 | 0.24 | 0.14 | 3.09 | Upgrade
|
| Receivables | 3.37 | 5.12 | 6.41 | 9.5 | 15.46 | 18.7 | Upgrade
|
| Prepaid Expenses | 1.84 | 0.05 | 0.06 | 0.06 | 0.06 | - | Upgrade
|
| Other Current Assets | - | 1.56 | 2.08 | 5.31 | 4.29 | 0.55 | Upgrade
|
| Total Current Assets | 5.64 | 9.8 | 9.88 | 18.95 | 28.8 | 42.19 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.94 | 2.82 | 1.19 | 3.47 | Upgrade
|
| Other Intangible Assets | 1,373 | 1,373 | 1,373 | 1,373 | 1,373 | 1,373 | Upgrade
|
| Total Assets | 1,379 | 1,383 | 1,384 | 1,395 | 1,403 | 1,419 | Upgrade
|
| Accounts Payable | 2.39 | 1.85 | 4.02 | 8.15 | 5.48 | 10.25 | Upgrade
|
| Accrued Expenses | 9.89 | 7.53 | 2.97 | 3.98 | 1.69 | 5.14 | Upgrade
|
| Short-Term Debt | 3.82 | 3.82 | 3.82 | 3.82 | 3.92 | 3.92 | Upgrade
|
| Current Portion of Long-Term Debt | 835.91 | 378.41 | 1,135 | 81.95 | 788.48 | 48.95 | Upgrade
|
| Current Portion of Leases | - | - | 0.97 | 1.88 | 1.12 | 2.29 | Upgrade
|
| Total Current Liabilities | 852 | 391.6 | 1,147 | 99.77 | 800.67 | 70.54 | Upgrade
|
| Long-Term Debt | 55.62 | 671.99 | 96.44 | 898.99 | 243.83 | 779.45 | Upgrade
|
| Long-Term Leases | - | - | - | 0.97 | - | 1.11 | Upgrade
|
| Total Liabilities | 907.62 | 1,064 | 1,243 | 999.73 | 1,045 | 851.11 | Upgrade
|
| Common Stock | 18.22 | 17.23 | 14.64 | 14.64 | 14.64 | 14.64 | Upgrade
|
| Additional Paid-In Capital | 1,406 | 1,376 | 1,119 | 1,119 | 1,119 | 1,119 | Upgrade
|
| Retained Earnings | -2,304 | -2,405 | -2,509 | -2,263 | -2,309 | -2,104 | Upgrade
|
| Comprehensive Income & Other | 420.11 | 400.33 | 579.67 | 579.68 | 579.49 | 579.53 | Upgrade
|
| Total Common Equity | -458.92 | -611.51 | -795.07 | -549.37 | -595.35 | -390.37 | Upgrade
|
| Minority Interest | 930.17 | 930.94 | 935.64 | 944.63 | 954.06 | 958.15 | Upgrade
|
| Shareholders' Equity | 471.25 | 319.43 | 140.56 | 395.27 | 358.71 | 567.77 | Upgrade
|
| Total Liabilities & Equity | 1,379 | 1,383 | 1,384 | 1,395 | 1,403 | 1,419 | Upgrade
|
| Total Debt | 895.34 | 1,054 | 1,236 | 987.6 | 1,037 | 835.71 | Upgrade
|
| Net Cash (Debt) | -894.91 | -1,051 | -1,235 | -983.52 | -1,028 | -812.78 | Upgrade
|
| Net Cash Per Share | -0.27 | -0.42 | -0.84 | -0.56 | -0.70 | -0.56 | Upgrade
|
| Filing Date Shares Outstanding | 1,822 | 1,723 | 1,464 | 1,464 | 1,464 | 1,464 | Upgrade
|
| Total Common Shares Outstanding | 1,822 | 1,723 | 1,464 | 1,464 | 1,464 | 1,464 | Upgrade
|
| Working Capital | -846.36 | -381.8 | -1,137 | -80.82 | -771.87 | -28.35 | Upgrade
|
| Book Value Per Share | -0.25 | -0.35 | -0.54 | -0.38 | -0.41 | -0.27 | Upgrade
|
| Tangible Book Value | -1,832 | -1,985 | -2,168 | -1,923 | -1,969 | -1,764 | Upgrade
|
| Tangible Book Value Per Share | -1.01 | -1.15 | -1.48 | -1.31 | -1.34 | -1.20 | Upgrade
|
| Machinery | - | - | - | - | - | 0.83 | Upgrade
|
Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.